Lupus

Air pollution exposure may worsen lupus in children, says study

smoke-258786_1920 copy 2The results of a study presented at the recent European League Against Rheumatism Annual Congress (EULAR 2016) show for the first time that an individual’s exposure to air pollution may have a direct role in triggering disease activity as well as airway inflammation in children and adolescents with Systemic Lupus Erythematosus (SLE). This study, conducted in Brazil, has confirmed a direct link between an individual’s personal exposure to fine pollution particles and their lupus disease activity. Continue reading

New treatment for lupus approved for limited use on the NHS

butterfly-17057_1920 copyThe National Institute for health and Care Excellence (NICE) has approved Belimumab (Benlysta) for limited use on the NHS for certain people with lupus in England and Wales.

This is the first new treatment for lupus for more than 50 years. NICE has said the drug would be made available under a managed access scheme between GlaxoSmithKline (GSK) and the NHS in England. Continue reading

Young people with lupus feel their condition is limiting their opportunities, says study

woman-1031111_1920 copyAccording to a new study, led by the University of Sydney, young people with lupus feel that their condition is limited their opportunities in life.

The researchers examined the experiences and perspectives of adolescents and young adults diagnosed with juvenile-onset systemic lupus erythematosus (SLE) from organised focus groups and face-to-face interviews with 26 patients aged between 14 and 26 years old, from five Australian hospitals in 2013 and 2014, which allowed them to identify key themes. Continue reading